Fecal microbiota transplant (FMT) has drawn intense interest as a way to treat disease, by adjusting our microbial makeup to harbor more “good” and fewer “bad” bacteria. Based on successful treatment of Clostridium difficile infections, FMT is now being looked at for a wide range of conditions.
The microbiome is thought to influence not only GI infection and disease, but also cancer, neurologic diseases, autism, obesity, metabolic diseases, psychiatric diseases, respiratory diseases and atherosclerosis. More than 200 FMT studies are currently registered on ClinicalTrials.gov, including several dozen pediatric studies. …Read More
The fecal microbiota transplantation (FMT) movement is catching the attention of scientists, researchers and the media nationwide. Currently, fecal transplantation delivers pre-screened, healthy human donor stool to a patient via colonoscopy or by nasogastric tube. It’s prescribed as an effective alternative to long-term antibiotic use in treating debilitating infectious diseases such as Clostridium difficile, also known as C-diff.